Numer badania | Tytuł badania | Nowotwór | Kategoria chorych | Faza badania | Sponsor badania | Data rozpoczęcia | Data zakończenia | Ośrodki badawcze | Sponsor badania | Linki |
---|---|---|---|---|---|---|---|---|---|---|
NCT00790036 | Phase III Study of RAD001 Adjuvant Therapy in Poor Risk... | DLBCL | III/IV stopień, CR po chemioterapii z rytuksymabem | III | Novartis | 2009-06-30 | 2014-04-30 |
Bydgoszcz; Łódź; Lublin; Warszawa
|
Novartis | |
NCT01337089 | Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as... | kontynuacja poprzedniego badania | III | GW Pharmaceuticals | 2010-12-31 | 2014-07-31 |
Bielsko-Biała; Gliwice; Poznań; Warszawa
|
GW Pharmaceuticals | ||
NCT01395017 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer | rak trzustki | II | Otsuka | 2011-05-31 | 2014-07-31 |
Lublin; Olsztyn
|
Otsuka | ||
NCT01217697 | Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer | rak gruczołu krokowego | leczenie bifosfonianami | III | J&J | 2010-10-31 | 2014-09-30 |
Gdańsk; Łódź; Opole; Otwock; Wrocław
|
J&J | |
NCT01160744 | A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin... | rak płuca | zaawansowany nowotwór | II | ImClone | 2010-08-31 | 2014-11-30 |
Gdańsk; Kościerzyna; Warszawa
|
ImClone | |
NCT01535209 | Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus... | przerzuty do mózgu | po resekcji pojedynczego ogniska | III | CO-I Warszawa | 2011-12-31 | 2014-11-30 |
CO-I Warszawa - Lucyna Kępka; Ph: 0048506118893; lucynak@coi.p
|
CO-I Warszawa | |
NCT01232556 | A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive... | NHL | oporny/nawrotowy | III | Pfizer | 2011-03-31 | 2015-11-30 |
Warszawa
|
Pfizer | |
NCT01100502 | A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients... | chłoniak Hodgkina | po przeszczepie | III | Seattle Genetics | 2010-03-31 | 2016-03-31 |
Klinika Hematologii UCK Gdańsk, Marcelina Paruch, Ph: +48 22 210... |
Seattle Genetics | |
NCT01285609 | Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing... | rak płuca | 1. linia | III | BMS | 2011-05-31 | 2016-05-31 |
Elbląg; Gdańsk; Olsztyn; Szczecin
|
BMS | |
NCT00646854 | Alemtuzumab and CHOP in T-cell Lymphoma | chłoniak T-kom | 1sza linia leczenia | III | Aarhus Universitetshospital | 2008-05-31 | 2016-11-30 |
CO-I Warszawa; prof.J.Walewski, walewski@coi.waw.pl
|
Aarhus Universitetshospital |